Preparation of Thermo-Responsive Molecular Imprinted Poly(Hydroxyethyl Methacrylate‑N-Isopropylacrylamide) Nanoparticles for Controlled Fluticasone Propionate Release and Greenness Assessment of MIP Nanoparticles
Fluticasone propionate (FP) is a potent glucocorticosteroid widely used in the treatment of various skin diseases, such as atopic dermatitis; however, when applied topically, it has low skin permeability and limited bioavailability. The purpose of this study was to produce the thermo-responsive molecular imprinted (MIP) poly(hydroxyethyl methacrylate-N-isopropylacrylamide)[p(HEMA-NIPAM)] nanoparticles for the controlled FP release. After 72 h, the amount of released FP from MIP nanoparticles was determined as 54.95 mg/g, significantly lower than that of nonimprinted (NIP) nanoparticles, which was 63.79 mg/g (p < 0.05). In the drug release kinetic analysis, the release of FP from MIP nanoparticles was found to be compatible with the Korsmeyer-Peppas model. After the experiments, the AGREEMIP tool was employed to assess the “greenness” of this MIP nanoparticles synthesis method indicating that the synthesized MIP nanoparticles procedure is at a relatively “good level” in terms of environmental friendliness. Consequently, the developed FP imprinted p(HEMA-NIPAM) nanoparticles are considered environmentally friendly materials with strong potential for the effective controlled release of drugs.
Authors
- Esra Feyzioğlu-Demir (ORCID: https://orcid.org/0000-0003-2012-4337)
- Tuğba Alhan
- Duru Mızıkoğlu
Institutions
- İzmir University of Economics (TR)
Publication Details
- Journal
- Polymer-Plastics Technology and Materials
- Published
- 2026-11-20
- DOI
- https://doi.org/10.1080/25740881.2026.2766408
- Primary Topic
- Nanoparticle-Based Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Türkiye Bilimsel ve Teknolojik Araştırma Kurumu
- Servier